APP
AppLovin Corporation
APP has the edge over OSCR overall, supported by stronger valuation and stronger modeled upside.
OSCR
Oscar Health, Inc.
OSCR's outlook is improving, though it still trails on the overall score.
APP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
APP's revenue, profitability, cash flow and balance sheet are all currently strong.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
APP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $394 | — |
| Current | 26x | $394 | — |
| Cheap | 42x | $618 | +57% |
| Fair | 66x | $978 | +148% |
| Expensive | 137x | $2,040 | +418% |
Historical ranges are pointers, not guarantees.
APP's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over APP in the historical PE scenario, which offers more potential upside but is not a forecast.
APP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for APP, with profitability improving.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
APP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.62 | +32% |
| Q3 2026 | $14.86 | +81% |
| Q2 2026 | $13.01 | +85% |
| Q1 2026 | $11.64 | +110% |
| Q4 2025 | $9.75 | +115% |
| Q3 2025 | $8.23 | +151% |
| Q2 2025 | $7.03 | +202% |
| Q1 2025 | $5.53 | +233% |
| Q4 2024 | $4.53 | +362% |
APP has the edge over OSCR on earnings, with more consistent year-over-year improvement.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
APP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +55% |
| Q2 2026 | $1.9B | +53% |
| Q1 2026 | $1.8B | +24% |
| Q4 2025 | $1.7B | +21% |
| Q3 2025 | $1.4B | +17% |
| Q2 2025 | $1.3B | +17% |
| Q1 2025 | $1.5B | +40% |
| Q4 2024 | $1.4B | +44% |
APP's revenue has grown year over year for 13 quarters in a row: $2.2B last quarter, up 55% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 78% | +1.4 points |
| Q2 2026 | 78% | +1.6 points |
| Q1 2026 | 78% | +33 points |
| Q4 2025 | 77% | +33 points |
| Q3 2025 | 77% | +32 points |
| Q2 2025 | 76% | +40 points |
| Q1 2025 | 45% | +13 points |
| Q4 2024 | 44% | +16 points |
APP has the edge over OSCR on profitability, with a higher operating margin.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over APP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
APP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +36% |
| Q2 2026 | $869M | +13% |
| Q1 2026 | $1.3B | +55% |
| Q3 2025 | $1.1B | +91% |
| Q2 2025 | $772.2M | +70% |
| Q1 2025 | $831.7M | +112% |
| Q3 2024 | $550.7M | +177% |
| Q2 2024 | $454.5M | +101% |
APP has the edge over OSCR on cash flow, with more consistent year-over-year improvement.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
APP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -2.3M shares |
| 1 year | -1.8% | -6.2M shares |
| 3 years | -6.2% | -22.1M shares |
| 5 years | -13% | -49.6M shares |
| Available history | +67% | +134M shares |
APP has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3B |
| Q2 2026 | $551.2M |
| Q1 2026 | $981.7M |
| Q4 2025 | $417.6M |
| Q3 2025 | $501.9M |
| Q2 2025 | $271.5M |
| Q1 2025 | $1B |
| Q4 2024 | $625,000 |
APP spent $3.2B buying back its own shares over the past year, up 82% from the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
APP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.2x | Healthy |
APP's net debt is less than a year of its operating earnings (EBITDA).
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over APP on leverage, with a lower net debt burden relative to earnings.
APP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 56.4 | Neutral |
APP's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
APP PE vs Technology Sector
| Metric | APP | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 28x | 4.9% below |
| PE % | 7 | 42 | 35 pts below |
APP is trading at 26x earnings, in line with the Technology sector's median of 28x.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over APP on valuation relative to its sector.
APP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $299.5 | 31% above |
| 20 week MA | $344.0 | 14% above |
| 50 week MA | $443.5 | 11% below |
| 100 week MA | $429.4 | 8.3% below |
| 200 week MA | $250.0 | 57% above |
APP's trend is mixed: it's above three of its five weekly moving averages, and 57% above its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over APP on trend strength, trading above more of its moving averages.
APP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $61.0 | $93.8 | +54% |
| 2022 | $93.8 | $9.84 | -90% |
| 2023 | $9.84 | $39.9 | +305% |
| 2024 | $39.9 | $335.2 | +741% |
| 2025 | $335.2 | $714.2 | +113% |
| 2026 YTD | $714.2 | $393.7 | -45% |
APP's yearly returns have swung widely, from +741% in 2024 to −90% in 2022. It's down 45% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over APP on returns for 2026, with the stronger performance.